Modeling prognostic factors in resectable pancreatic adenocarcinomas
- PMID: 20508721
- PMCID: PMC2865167
- DOI: 10.4137/cin.s3835
Modeling prognostic factors in resectable pancreatic adenocarcinomas
Abstract
Background: The accurate prognosis for patients with resectable pancreatic adenocarcinomas requires the incorporation of more factors than those included in AJCC TNM system.
Methods: We identified 218 patients diagnosed with stage I and II pancreatic adenocarcinoma at NewYork-Presbyterian Hospital/Columbia University Medical Center (1999 to 2009). Tumor and clinical characteristics were retrieved and associations with survival were assessed by univariate Cox analysis. A multivariable model was constructed and a prognostic score was calculated; the prognostic strength of our model was assessed with the concordance index.
Results: Our cohort had a median age of 67 years and consisted of 49% men; the median follow-up time was 14.3 months and the 5-year survival 3.6%. Age, tumor differentiation and size, alkaline phosphatase, albumin and CA 19-9 were the independent factors of the final multivariable model; patients were thus classified into low (n = 14, median survival = 53.7 months), intermediate (n = 124, median survival = 19.7 months) and high risk groups (n = 80, median survival = 12.3 months). The prognostic classification of our model remained significant after adjusting for adjuvant chemotherapy and the concordance index was 0.73 compared to 0.59 of the TNM system.
Conclusion: Our prognostic model was accurate in stratifying patients by risk and could be incorporated into clinical decisions.
Keywords: multivariable model; pancreatic adenocarcinomas; prognosis; survival.
Figures

References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49. - PubMed
-
- Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79. - PubMed
-
- Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456–62. - PubMed
-
- Zuckerman DS, Ryan DP. Adjuvant therapy for pancreatic cancer: a review. Cancer. 2008;112:243–9. - PubMed
-
- Labianca R, Berardi E, Malugani F. Challenges in the treatment of gastrointestinal tumours. Ann Oncol. 2006;17(Suppl 5):v137–41. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources